文献速递临床微生物分子诊断

泌尿生殖道脑膜炎奈瑟菌被核酸扩增检测误判为淋病奈瑟菌的基因组特征

Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing.
PubMed 文献 · J Clin Microbiol · 2021-01-21

研究对泌尿生殖道培养出的脑膜炎奈瑟菌和淋病奈瑟菌进行鉴定方法比较与全基因组测序。MALDI-TOF MS、MLST、16S rRNA和ANI准确鉴定95%(18/19)分离株;Aptima Combo 2 CT/NG将30%(3/10)脑膜炎奈瑟菌误判为淋病奈瑟菌,Xpert CT/NG无此误判。泌尿生殖道脑膜炎奈瑟菌主要对阿奇霉素耐药。

要点

  • Aptima Combo 2 CT/NG可将泌尿生殖道脑膜炎奈瑟菌误判为淋病奈瑟菌
  • Xpert CT/NG未发现脑膜炎奈瑟菌与淋病奈瑟菌的误判
  • 泌尿生殖道脑膜炎奈瑟菌主要对阿奇霉素耐药,淋病奈瑟菌对阿奇霉素敏感

核心结论

  • 泌尿生殖道脑膜炎奈瑟菌可导致淋病奈瑟菌诊断试验假阳性。
  • 泌尿生殖道脑膜炎奈瑟菌误判可能干扰淋病相关的公共卫生工作。
  • 需进一步研究泌尿生殖道脑膜炎奈瑟菌感染对临床结局的影响。

研究设计与样本

  • 研究纳入有症状、疑似淋病患者泌尿生殖道培养出的连续脑膜炎奈瑟菌分离株,以及同一人群同一时间段随机选取的淋病奈瑟菌分离株。
  • 采用常规鉴定系统、抗菌药物敏感性试验和全基因组测序对分离株进行表征。

主要发现

  • MALDI-TOF MS、MLST、16S rRNA基因测序和ANI方法准确鉴定95%(18/19)的脑膜炎奈瑟菌和淋病奈瑟菌分离株。
  • Aptima Combo 2 CT/NG试验将30%(3/10)的脑膜炎奈瑟菌分离株误判为淋病奈瑟菌。
  • Xpert CT/NG核酸检测未发现脑膜炎奈瑟菌与淋病奈瑟菌的误判。
  • 系统发育核心基因组和SNP分组分析显示泌尿生殖道脑膜炎奈瑟菌分离株高度相关,与淋病奈瑟菌及呼吸道脑膜炎奈瑟菌分离株系统发育不同,但与引起美国尿道炎患者的泌尿生殖道脑膜炎奈瑟菌分离株相似。
  • 泌尿生殖道脑膜炎奈瑟菌分离株主要对阿奇霉素耐药,而淋病奈瑟菌分离株对阿奇霉素敏感。

关键数值与推荐

  • MALDI-TOF MS、MLST、16S rRNA基因测序和ANI方法对脑膜炎奈瑟菌和淋病奈瑟菌分离株的准确鉴定率为95%(18/19)。
  • Aptima Combo 2 CT/NG试验对脑膜炎奈瑟菌分离株的误判率为30%(3/10)。
  • 泌尿生殖道脑膜炎奈瑟菌分离株主要对阿奇霉素耐药,淋病奈瑟菌分离株对阿奇霉素敏感。

临床怎么用

  • 对泌尿生殖道标本进行淋病奈瑟菌核酸检测时,应意识到脑膜炎奈瑟菌可能导致假阳性,尤其使用Aptima Combo 2 CT/NG试验时。
  • Xpert CT/NG核酸检测未出现脑膜炎奈瑟菌误判,可作为减少假阳性的可选方法。
  • 对泌尿生殖道脑膜炎奈瑟菌分离株应进行抗菌药物敏感性试验,因其可能对阿奇霉素耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neisseria meningitidis and Neisseria gonorrhoeae are pathogenic bacteria that can cause human infections. While N. meningitidis infections are associated with bacterial meningitis and bacteremia, a strain of N. meningitidis, isolated from the urogenital system, has recently been associated with urethritis. As this strain is becoming prominent as an emerging pathogen, it is essential to assess identification tools for N. meningitidis and N. gonorrhoeae urogenital isolates. Consecutive N. meningitidis isolates recovered from urogenital cultures of symptomatic patients with presumptive diagnoses of gonorrhea and a random selection of N. gonorrhoeae isolates recovered from the same population within the same time frame were characterized with routine identification systems, antimicrobial susceptibility testing, and whole-genome sequencing. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), multilocus sequence typing, 16S rRNA gene sequence, and average nucleotide identity methods accurately identified 95% (18/19) of N. meningitidis and N. gonorrhoeae isolates. With the Aptima Combo 2 CT/NG test, 30% (3/10) of N. meningitidis isolates were misidentified as N. gonorrhoeae, but no misidentifications were found with the Xpert CT/NG nucleic acid amplification test (NAAT). Phylogenetic core genome and single nucleotide polymorphism (SNP)-based grouping analyses showed that urogenital N. meningitidis isolates were highly related and phylogenetically distinct from N. gonorrhoeae and respiratory N. meningitidis isolates but similar to urogenital N. meningitidis isolates from patients with urethritis in the United States. Urogenital N. meningitidis isolates were predominantly azithromycin resistant, while N. gonorrhoeae isolates were azithromycin susceptible. These data indicate that urogenital isolates of N. meningitidis can cause false-positive detections with N. gonorrhoeae diagnostic assays. Misidentification of urogenital N. meningitidis isolates may confound public health-related activities for gonorrhea, and future studies are needed to understand the impact on clinical outcome of N. meningitidis urogenital infection.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Sukhum KV, Jean S, Wallace M, et al. Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing. J Clin Microbiol. 2021. PMID: 33177123. doi:10.1128/JCM.01699-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。